GSA CAPITAL PARTNERS LLP - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 183 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$116
+41.5%
296,948
+196.1%
0.01%
+25.0%
Q1 2023$82
-67.2%
100,274
-37.4%
0.01%
-74.2%
Q4 2022$250
-99.6%
160,080
+313.1%
0.03%
+210.0%
Q2 2022$67,000
-80.7%
38,755
-60.1%
0.01%
-78.7%
Q1 2022$348,000
+27.0%
97,040
+76.6%
0.05%
+38.2%
Q4 2021$274,000
+12.8%
54,957
+62.1%
0.03%
+36.0%
Q3 2021$243,000
+10.5%
33,894
+43.0%
0.02%0.0%
Q2 2021$220,000
-3.5%
23,706
-3.5%
0.02%
-34.2%
Q1 2021$228,000
+36.5%
24,566
+30.0%
0.04%
+40.7%
Q4 2020$167,000
-18.1%
18,890
-31.2%
0.03%
-47.1%
Q1 2020$204,000
-72.1%
27,450
-76.2%
0.05%
+2.0%
Q3 2017$731,000
-29.4%
115,300
-12.7%
0.05%
-26.5%
Q2 2017$1,035,000
+17.6%
132,000
+39.8%
0.07%
+44.7%
Q3 2016$880,000
+37.7%
94,400
+36.4%
0.05%
+34.3%
Q2 2016$639,000
+189.1%
69,200
+172.4%
0.04%
+150.0%
Q1 2016$221,000
-8.3%
25,400
-29.1%
0.01%
+16.7%
Q4 2015$241,000
-65.7%
35,800
-58.5%
0.01%
-55.6%
Q2 2015$703,000
+144.1%
86,200
+144.2%
0.03%
+145.5%
Q1 2015$288,000
+89.5%
35,300
+129.2%
0.01%
+37.5%
Q3 2014$152,00015,4000.01%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
CAXTON ASSOCIATES LP 784,679$643,4370.10%
Green Alpha Advisors, LLC 146,300$119,9660.08%
Virtus ETF Advisers LLC 54,106$44,3670.02%
Cedar Brook Financial Partners, LLC 104,881$86,0020.02%
PROFUND ADVISORS LLC 418,749$343,3740.02%
Arlington Capital Management, Inc. 27,735$22,7430.02%
Hennion & Walsh Asset Management, Inc. 382,158$3130.02%
Rafferty Asset Management, LLC 2,647,927$2,171,3000.02%
Brainard Capital Management LLC 16,666$13,6660.01%
Beck Bode, LLC 41,218$33,7990.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders